AACR Cancer Progress Report 2022
What Is Cancer Precision Medicine? Research has powered an explosion in our understanding of the biology of cancer genomics and is leading to tailored treatments for patients.
Read the Report
What Is Cancer Precision Medicine? Research has powered an explosion in our understanding of the biology of cancer genomics and is leading to tailored treatments for patients.
Read the Report
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn More
A career development grant from the AACR helped Yale University cancer scientist Luisa Escobar-Hoyos, MSc, PhD, earn two major, multi-year federal grants to further develop her research.
Read AACR Stories
More than 150,000 people in the United States are expected to be diagnosed with colorectal cancer this year. Read about the prevention, screening, and treatment options for colorectal cancer.
Learn More
Rules for Healthy Living: Updated guideline reinforces the role of plant-based foods and heart-pumping activities for cancer survivors.
Read Practical Knowledge
Many Americans are unaware that consuming alcoholic beverages increases the risk for cancer, a study based on data from the 2020 Health Information National Trends Survey (HINTS).
Learn More
The AACR is the worldwide leader in advancing the science of cancer health disparities. Give now and 100% of your donation will support AACR’s diversity, equity, and inclusion initiatives.
Donate Now
The AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world. Register to attend by the early registration deadline of December 16, 2022.
The AACR Cancer Progress Report 2022 provides a comprehensive overview of the latest research-driven advances against the collection of devastating diseases called cancer.
Learn MoreThe AACR and its more than 50,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreAACR President Lisa M. Coussens, PhD, FAACR, discusses the research-driven advances against cancer and looks to the future of cancer science and medicine.
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn Morenew therapeutics against cancer were approved by the FDA from August 1, 2020, to July 31, 2021
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2018
Learn MoreYour donation to the American Association for Cancer Research helps our more than 50,000 members worldwide drive progress against cancer.
Donate Now